Tempus AI Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: $70.19 High: $75.72
on August 15, 2025

52 Week Range

Low: $31.36 High: $91.45
on January 13, 2025
on February 14, 2025

All-Time High: $91.45 on February 10, 2025

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $12.4B
EPS i 2.15
P/E Ratio (TTM) i 33.14
Forward P/E i -101.79
P/B Ratio i 39.94
PEG Ratio i -0.34
Div. Yield i N/A
ROE i -97.95%
Beta i N/A
Debt to Equity i 275.63

Financial Highlights

Profitability

Gross Margin i 61.99%
Operating Margin i -19.00%
Profit Margin i -20.98%

Returns and Earnings

Return on Assets (TTM) i -11.51%
Return on Equity (TTM) i -97.95%
EBITDA i $-162.1M
Net Income (TTM) i $-199.7M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i $5.88
Quarterly Revenue Growth (YoY) i 89.60%
Quarterly Earnings Growth (YoY) i 89.57%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Tempus AI TEM 12.38B Large-cap21.26%32.06%17.91%-9.93%115.50%45.01%83.30%83.30%
Veeva Systems VEEV 45.62B Large-cap-0.51%0.49%16.18%20.56%33.30%45.77%28.01%5.12%
Ge Healthcare GEHC 33.97B Large-cap1.94%-1.33%0.67%-20.79%-6.35%-13.44%29.36%29.36%
Doximity DOCS 11.58B Large-cap-2.18%4.96%11.43%-16.42%21.60%82.18%97.30%16.35%
HealthEquity HQY 7.72B Mid-cap-3.40%-6.54%-7.95%-20.62%-7.15%20.05%46.16%66.28%
Waystar Holding WAY 6.19B Mid-cap4.34%-4.95%-8.05%-20.00%0.39%40.01%74.30%74.30%

Ownership & Short Interest

Insider Ownership i 43.11%
Institutional Ownership i 41.69%
Shares Short i 23M
Short Ratio i 2.59
Short % of Shares Outstanding i 18.39%
Average 10-Day Volume i 9M
Average 90-Day Volume i 9M

Tempus AI Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Tempus AI would have performed over time.

$
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Tempus AI reached a high of $91.45 (on February 14, 2025) and a low of $31.36 (on January 13, 2025).
Curious about Tempus AI's size and valuation? Its market capitalization stands at 12.38B. When it comes to valuation, the P/E ratio (trailing twelve months) is 33.14, and the forward P/E (looking ahead) is -101.79.
As for dividends, Tempus AI isn't currently offering a significant yield, or that specific data isn't available right now.

When looking at Tempus AI, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Veeva Systems
VEEV
45.62BHealthcareHealth Information Services45.77%28.01%
Ge Healthcare
GEHC
33.97BHealthcareHealth Information Services-13.44%29.36%
Doximity
DOCS
11.58BHealthcareHealth Information Services82.18%97.30%
HealthEquity
HQY
7.72BHealthcareHealth Information Services20.05%46.16%
Waystar Holding
WAY
6.19BHealthcareHealth Information Services40.01%74.30%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Tempus AI's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -97.95%, the Debt to Equity ratio from the most recent quarter is 275.63, and its Gross Profit Margin stands at 61.99%.
Looking at Tempus AI's growth, its revenue over the trailing twelve months (TTM) was $952M. Compared to the same quarter last year (YoY), quarterly revenue grew by 89.60%, and quarterly earnings saw a YoY growth of 89.57%.
Wondering who owns Tempus AI stock? Company insiders (like executives and directors) hold about 43.11% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 41.69%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.